应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
01609 天星医疗
待上市 04-24 16:00:00
98.500
+0.000
0.00%
最高
98.500
最低
98.500
成交量
0.00
今开
98.500
昨收
98.500
日振幅
0.00%
总市值
45.71亿
流通市值
54.01亿
总股本
4,641万
成交额
0.00
换手率
0.00%
流通股本
5,483万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
新股孖展统计 | 4月24日
智通财经网 · 04-24 19:43
新股孖展统计 | 4月24日
新股招股 | 天星医疗今日起至4月29日招股,一手入场费4974.67港元
老虎资讯综合 · 04-24 08:54
新股招股 | 天星医疗今日起至4月29日招股,一手入场费4974.67港元
北京天星医疗启动全球发售,专注运动医学器械业务
公告速递 · 04-24 06:20
北京天星医疗启动全球发售,专注运动医学器械业务
创建集团控股将失去上市地位,投资者需关注后续动态
和讯网 · 2024-03-27
创建集团控股将失去上市地位,投资者需关注后续动态
联交所:创建集团(01609.HK)下月2日起除牌
阿斯达克财经 · 2024-03-27
联交所:创建集团(01609.HK)下月2日起除牌
创建集团控股(01609)上市地位将于4月2日起取消
智通财经 · 2024-03-27
创建集团控股(01609)上市地位将于4月2日起取消
创建集团控股(01609.HK)4月2日取消上市地位
阿斯达克财经 · 2024-03-20
创建集团控股(01609.HK)4月2日取消上市地位
创建集团控股(01609):上市地位将自4月2日起被取消
智通财经 · 2024-03-20
创建集团控股(01609):上市地位将自4月2日起被取消
创建集团控股(01609)提请上市复核委员会复核除牌决定 继续停牌
智通财经 · 2023-12-04
创建集团控股(01609)提请上市复核委员会复核除牌决定 继续停牌
创建集团控股发布中期业绩 净利润751.1万港元同比下降53.9%
新浪港股 · 2023-11-24
创建集团控股发布中期业绩 净利润751.1万港元同比下降53.9%
创建集团控股(01609.HK)中期收益减少10.0%至约2.215亿港元
格隆汇资讯 · 2023-11-23
创建集团控股(01609.HK)中期收益减少10.0%至约2.215亿港元
创建集团控股(01609)发布中期业绩,净利润751.1万港元,同比下降53.9%
智通财经网 · 2023-11-23
创建集团控股(01609)发布中期业绩,净利润751.1万港元,同比下降53.9%
创建集团控股:中期净利约750万港元,毛利约为2620万港元
金融界港股 · 2023-11-23
创建集团控股:中期净利约750万港元,毛利约为2620万港元
创建集团控股拟1.42亿港元收购广州市祥景陵园59%股权
新浪港股 · 2023-11-22
创建集团控股拟1.42亿港元收购广州市祥景陵园59%股权
创建集团控股(01609.HK)拟1.42亿港元收购广州市祥景陵园59%股权
格隆汇资讯 · 2023-11-21
创建集团控股(01609.HK)拟1.42亿港元收购广州市祥景陵园59%股权
创建集团控股(01609.HK)拟11月23日召开董事会会议审批中期业绩
格隆汇资讯 · 2023-11-06
创建集团控股(01609.HK)拟11月23日召开董事会会议审批中期业绩
加载更多
公司概况
公司名称:
天星医疗
所属市场:
SEHK
上市日期:
--
主营业务:
北京天星医疗股份有限公司(简称“天星医疗”)作为国产运动医学的领导者,致力于提供运动医学的整体临床解决方案,公司坐落于北京经济技术开发区,注册资本4000多万,现有员工200余人。应用于肩关节、膝关节、足/踝关节、髋关节、肘关节、手/腕关节的运动医学设备、植入物和手术器械共计300多个品规通过NMPA的批准,临床应用于国内31个省市、自治区的数千家医院。主要从事运动医学植入物、有源设备及耗材,以及手术工具的研发、生产与销售。
发行价格:
--
{"stockData":{"symbol":"01609","market":"HK","secType":"STK","nameCN":"天星医疗","latestPrice":98.5,"timestamp":1777017600000,"preClose":98.5,"halted":9,"volume":0,"delay":0,"changeRate":0,"floatShares":54831344,"shares":46409494,"eps":0.021242,"marketStatus":"待上市","change":0,"latestTime":"04-24 16:00:00","open":98.5,"high":98.5,"low":98.5,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":0.013072,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1777944600000},"marketStatusCode":8,"adr":0,"listingDate":1777910400000,"exchange":"SEHK","adjPreClose":98.5,"openAndCloseTimeList":[[1776994200000,1777003200000],[1777006800000,1777017600000]],"volumeRatio":0,"ipoDetail":{"name":"天星医疗","exchange":"SEHK","listingDate":"2026-05-05","sharesOutstanding":54831344,"sharesFloat":54831344,"offerAmount":8421900,"priceRange":"98.500","market":"HK","openProspectusDate":"2026-04-24","openProspectusUrl":"https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0424/2026042400054_c.pdf","purchaseBeginDate":"2026-04-24","purchaseEndDate":"2026-04-29","winningDate":"2026-05-04","currency":"HKD","minPurchaseQuantity":2000,"peRate":35.68,"use":"1、约30.0%或227.5百万港元,将用于扩大生产能力并提升生产效率,以便能够满足快速增长的市场需求;\n2、约35.0%或265.5百万港元,将用于支持以患者为导向的产品策略的研发工作;\n3、约25.0%或189.6百万港元,将用于商业化、销售及市场推广活动,以巩固在中国的领先地位并建立全球市场存在及品牌形象;\n4、约10.0%或75.8百万港元,将用于营运资金及一般企业用途。","industryId":"204005","industryName":"医疗保健","business":"公司是一家立足中国的医疗器械公司,专注于运动医学临床解决方案。据灼识咨询数据,按2024年销售收入计,公司是中国第四大运动医学设备提供商,市场份额约占中国运动医学植入物及器械市场的6.5%,也是最大的国产运动医学设备提供商。依托自主研发的植入物、有源设备、相关耗材及手术器械,公司提供肩袖、韧带、半月板等软组织损伤治疗,也提供运动康复及预防的全方位解决方案。","subscribed":85.13,"marketCap":5401000000,"minimumCapital":4974.67,"overAllotment":false,"lotSize":50,"issueOpenRate":0.1,"subscribeGear":"50,100,150,200,250,300,350,400,450,500,600,700,800,900,1000,1500,2000,2500,3000,3500,4000,4500,5000,10000,15000,20000,25000,30000,35000,40000,45000,50000,60000,70000,80000,90000,100000,150000,200000,250000,300000,350000,421100","issueRatio":0.1,"offeringMechanism":"B"},"greyMarketDetail":{"greyDate":"2026-05-04","greyDateTimestamp":1777824000000,"greyOpeningTime":1777882500000,"greyClosingTime":1777890600000,"showGreyQuote":false,"openProspectusDate":"2026-04-24","listingDate":"2026-05-05"},"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01609","defaultTab":"news","newsList":[{"id":"2629084951","title":"新股孖展统计 | 4月24日","url":"https://stock-news.laohu8.com/highlight/detail?id=2629084951","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629084951?lang=zh_cn&edition=full","pubTime":"2026-04-24 19:43","pubTimestamp":1777031033,"startTime":"0","endTime":"0","summary":"天星医疗(01609)、商米科技(06810)正在招股中。","market":"sh","thumbnail":"https://img.zhitongcaijing.com/image/20260424/20260424194418_26457.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260424/20260424194418_26457.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1433624.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1148","01609","06810"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179248654","title":"新股招股 | 天星医疗今日起至4月29日招股,一手入场费4974.67港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1179248654","media":"老虎资讯综合","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1179248654?lang=zh_cn&edition=full","pubTime":"2026-04-24 08:54","pubTimestamp":1776992046,"startTime":"0","endTime":"0","summary":"$天星医疗$ 今日至4月29日招股,拟全球发售842.185万股H股,香港公开发售占10%,国际发售占90%。每股发售股份98.50港元,每手50股,一手入场费4974.67港元,预期股份将于2026年5月5日(星期二)上午九时正开始在联交所买卖。约25.0%将用于商业化、销售及市场推广活动,以巩固公司在中国的领先地位并建立全球市场存在及品牌形象。","market":"us","thumbnail":"https://community-static.tradeup.com/news/b85fee256ef052cf88ac937d1959d694","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/b85fee256ef052cf88ac937d1959d694"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"3430ee0e05254278b5a3da84a7b77b4c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01609"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1125838440","title":"北京天星医疗启动全球发售,专注运动医学器械业务","url":"https://stock-news.laohu8.com/highlight/detail?id=1125838440","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1125838440?lang=zh_cn&edition=full","pubTime":"2026-04-24 06:20","pubTimestamp":1776982851,"startTime":"0","endTime":"0","summary":"北京天星医疗股份有限公司是一家主要面向运动医学临床解决方案的医疗器械企业,通过植入物、手术设备及相关耗材等核心产品,为关节、韧带和软组织损伤等场景提供诊疗和康复支持。公司在运动医学器械领域的业务涵盖植入物及相应手术设备、耗材等,并持续投入研发与产品升级。本次全球发售所得款项将主要用于扩大产能、增强产品竞争力及加强推广,进一步巩固公司在运动医学器械市场的地位,同时维持营运资金流动性。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"北京天星医疗启动全球发售,专注运动医学器械业务","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01609"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2422917002","title":"创建集团控股将失去上市地位,投资者需关注后续动态","url":"https://stock-news.laohu8.com/highlight/detail?id=2422917002","media":"和讯网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2422917002?lang=zh_cn&edition=full","pubTime":"2024-03-27 23:32","pubTimestamp":1711553550,"startTime":"0","endTime":"0","summary":"对于二级市场投资者而言,这无疑是一条备受关注的财经新闻。创建集团控股作为一家在香港联交所上市的公司,其上市地位的取消将直接影响到投资者的投资决策。这一消息的公布引发了市场的广泛关注。创建集团控股失去上市地位的消息给我们带来了一个重要的启示:投资者在进行投资时,需要全面考虑公司的经营状况和财务情况,并及时关注市场的动态变化。只有这样,才能够做出明智的投资决策,保护自己的投资利益。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403280001278b6a3be9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403280001278b6a3be9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1148","01609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2422952737","title":"联交所:创建集团(01609.HK)下月2日起除牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2422952737","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2422952737?lang=zh_cn&edition=full","pubTime":"2024-03-27 17:05","pubTimestamp":1711530300,"startTime":"0","endTime":"0","summary":"联交所宣布,由下周二(4月2日)上午9时起,创建集团(01609.HK) 的上市地位将根据《上市规则》第6.01A(1)条予以取消。(sl/da)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"fut","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20190702160157314_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20190702160157314_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1337742/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1337742/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["01609","BK1148"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2422957975","title":"创建集团控股(01609)上市地位将于4月2日起取消","url":"https://stock-news.laohu8.com/highlight/detail?id=2422957975","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2422957975?lang=zh_cn&edition=full","pubTime":"2024-03-27 17:03","pubTimestamp":1711530204,"startTime":"0","endTime":"0","summary":"智通财经APP讯,创建集团控股(01609)发布公告,香港联合交易所有限公司(联交所)宣布,由2024年4月2日上午9时起,创建集团(控股)有限公司(该公司)的上市地位将根据《上市规则》第6.01A(1)条予以取消。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1093380.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01609","BK1148"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2420371503","title":"创建集团控股(01609.HK)4月2日取消上市地位","url":"https://stock-news.laohu8.com/highlight/detail?id=2420371503","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2420371503?lang=zh_cn&edition=full","pubTime":"2024-03-20 17:45","pubTimestamp":1710927900,"startTime":"0","endTime":"0","summary":"创建集团控股(01609.HK) 公布,由于公司未能于2023年11月12日前履行联交所订下的复牌指引及恢复其股份买卖,根据上市规则第6.01A条,公司股份的上市地位将被取消。股份的最后上市日期将为2024年3月28日,及股份的上市地位将自2024年4月2日上午九时正起被取消。(ha/a)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"us","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20230531123540477_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20230531123540477_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1335091/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1335091/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["01609","BK1148"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2420371557","title":"创建集团控股(01609):上市地位将自4月2日起被取消","url":"https://stock-news.laohu8.com/highlight/detail?id=2420371557","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2420371557?lang=zh_cn&edition=full","pubTime":"2024-03-20 17:37","pubTimestamp":1710927437,"startTime":"0","endTime":"0","summary":"智通财经APP讯,创建集团控股(01609)发布公告,联交所于2024年3月19日发出函件通知公司,由于公司未能于2023年11月12日前履行联交所订下的复牌指引及恢复其股份买卖,根据上市规则第6.01A条,公司股份的上市地位将被取消。股份的最后上市日期将为2024年3月28日,及股份的上市地位将自2024年4月2日上午九时正起被取消。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1089126.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1148","01609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2388734859","title":"创建集团控股(01609)提请上市复核委员会复核除牌决定 继续停牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2388734859","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2388734859?lang=zh_cn&edition=full","pubTime":"2023-12-04 21:16","pubTimestamp":1701695814,"startTime":"0","endTime":"0","summary":"智通财经APP讯,创建集团控股(01609)发布公告,公司接获联交所日期为2023年11月24日的函件,表示联交所上市委员会已决定根据上市规则第6.01A条撤销公司的上市地位,原因为公司未能符合复牌指引。根据上市规则第2B章,公司有权于发出该决定之日起计七个营业日内提请联交所上市复核委员会复核该决定。倘公司决定不申请复核,公司股份的最后上市日期将为2023年12月8日,而其股份的上市地位将自2023年12月11日上午9时正起被撤销。于2023年12月4日,公司已根据上市规则第2B章提交申请,提请上市复核委员会复核该决定。公司股份继续停牌。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1033283.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01609","BK1148"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2385311670","title":"创建集团控股发布中期业绩 净利润751.1万港元同比下降53.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2385311670","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2385311670?lang=zh_cn&edition=full","pubTime":"2023-11-24 08:31","pubTimestamp":1700785908,"startTime":"0","endTime":"0","summary":"创建集团控股(01609)发布截至2023年9月30日止六个月业绩,收益2.215亿港元,同比下降9.9%;净利润751.1万港元,同比下降53.9%;每股基本盈利0.76港元。\n\n现在送您60元福利红包,直接提现不套路~~~快来参与活动吧!\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-11-24/doc-imzvsnea4859853.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-11-24/doc-imzvsnea4859853.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_sina","symbols":["01609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2385362509","title":"创建集团控股(01609.HK)中期收益减少10.0%至约2.215亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2385362509","media":"格隆汇资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2385362509?lang=zh_cn&edition=full","pubTime":"2023-11-23 20:07","pubTimestamp":1700741221,"startTime":"0","endTime":"0","summary":"格隆汇11月23日丨创建集团控股(01609.HK)公告,截至2023年9月30日止六个月,公司收益减少10.0%至约2.215亿港元。收益减少主要是由于来自混凝土浇注服务业务的收益减少。集团于报告期间的期内纯利约为750万港元,而上一期间的期内纯利约为1,630万港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023112320090382004c3f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023112320090382004c3f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01609","BK1148"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2385756625","title":"创建集团控股(01609)发布中期业绩,净利润751.1万港元,同比下降53.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2385756625","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2385756625?lang=zh_cn&edition=full","pubTime":"2023-11-23 20:04","pubTimestamp":1700741040,"startTime":"0","endTime":"0","summary":"创建集团控股(01609)发布截至2023年9月30日止六个月业绩,收益2.215亿港元,同比下降9.9%;净利润751.1万港元,同比下降53.9%;每股基本盈利0.76港元。收益减少主要是由于来自混凝土浇注服务业务的收益减少。于报告期间,混凝土浇注服务业务收益约为2.184亿港元,较上一期间的约2.422亿港元减少9.8%。收益下降乃由于新项目金额及数目同样较上一期间减少。\n\n现在送您60元福利红包,直接提现不套路~~~快来参与活动吧!\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-11-23/doc-imzvrksm4303668.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["01609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2385626660","title":"创建集团控股:中期净利约750万港元,毛利约为2620万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2385626660","media":"金融界港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2385626660?lang=zh_cn&edition=full","pubTime":"2023-11-23 20:02","pubTimestamp":1700740970,"startTime":"0","endTime":"0","summary":"金融界11月23日消息,创建集团控股报告截至2023年9月30日止六个月的财务业绩,公司收入约为2.215亿港元,期内净利约为750万港元,此数据未经审核。毛利约为2620万港元,较去年同期减少。期间混凝土浇注服务业务收入约为2.184亿港元,比上年同期减少。此外,香港联交所指示其股份自2022年5月13日起暂停交易,公司已针对此事向香港高等法院提交司法复核请求,并以新上市申请人身份致力恢复股份交易。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2023/11/23200238545191.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["01609","BK1148"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2385501777","title":"创建集团控股拟1.42亿港元收购广州市祥景陵园59%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2385501777","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2385501777?lang=zh_cn&edition=full","pubTime":"2023-11-22 08:26","pubTimestamp":1700612766,"startTime":"0","endTime":"0","summary":"创建集团控股发布公告,于2023年11月21日,该公司、卖方与担保人订立协议,该公司有条件同意收购而卖方有条件同意出售销售权益,即目标公司广州市祥景陵园59%股权。收购事项的代价为1.42亿港元,部分由该公司以现金支付,部分以向卖方进行贷款转让的方式支付。 目标公司主要于中国广州从事提供殡葬服务,其经营位于广州黄埔祥景陵园土地的祥景陵园。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-11-22/doc-imzvmxxw7574943.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-11-22/doc-imzvmxxw7574943.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_sina","symbols":["BK1148","01609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2385176524","title":"创建集团控股(01609.HK)拟1.42亿港元收购广州市祥景陵园59%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2385176524","media":"格隆汇资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2385176524?lang=zh_cn&edition=full","pubTime":"2023-11-21 21:56","pubTimestamp":1700574986,"startTime":"0","endTime":"0","summary":"格隆汇11月21日丨创建集团控股(01609.HK)公告,于2023年11月21日,公司(作为买方)、卖方广州联成文化科技有限公司与担保人订立协议,据此,公司有条件同意收购而卖方有条件同意出售销售权益,即目标公司广州市祥景陵园有限公司59%股权。收购事项的代价为1.42亿港元,部分由公司以现金支付,部分以向卖方进行贷款转让的方式支付。目标公司主要于中国广州从事提供殡葬服务,其经营位于广州黄埔祥景陵园土地的祥景陵园。于往绩记录期间,目标公司分别录得未经审核除税后纯利约人民币36.9百万元、人民币40.3百万元、人民币35.3百万元及人民币39.0百万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023112121580381f7c917&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023112121580381f7c917&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1148","01609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2381177036","title":"创建集团控股(01609.HK)拟11月23日召开董事会会议审批中期业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2381177036","media":"格隆汇资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2381177036?lang=zh_cn&edition=full","pubTime":"2023-11-06 21:38","pubTimestamp":1699277926,"startTime":"0","endTime":"0","summary":"格隆汇11月6日丨创建集团控股(01609.HK)公告,将于2023年11月23日(星期四)举行董事会会议,以考虑及批准(其中包括)公司及其附属公司截至2023年9月30日止6个月的未经审核中期业绩及派付中期股息(如有),并处理任何其他事务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202311062141018251559b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202311062141018251559b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1148","01609"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.starsportmed.com/","compareEarnings":[{"period":"1week","weight":-0.007},{"period":"1month","weight":0.0253},{"period":"3month","weight":-0.0288},{"period":"6month","weight":-0.007},{"period":"1year","weight":0.1857},{"period":"ytd","weight":0.0136}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"北京天星医疗股份有限公司(简称“天星医疗”)作为国产运动医学的领导者,致力于提供运动医学的整体临床解决方案,公司坐落于北京经济技术开发区,注册资本4000多万,现有员工200余人。应用于肩关节、膝关节、足/踝关节、髋关节、肘关节、手/腕关节的运动医学设备、植入物和手术器械共计300多个品规通过NMPA的批准,临床应用于国内31个省市、自治区的数千家医院。主要从事运动医学植入物、有源设备及耗材,以及手术工具的研发、生产与销售。","yearOnYearQuotes":[{"month":1,"riseRate":1,"avgChangeRate":0.121197},{"month":2,"riseRate":0.5,"avgChangeRate":0.06192},{"month":3,"riseRate":0.428571,"avgChangeRate":0.034993},{"month":4,"riseRate":0.5,"avgChangeRate":-0.011524},{"month":5,"riseRate":0.5,"avgChangeRate":0.066004},{"month":6,"riseRate":0.2,"avgChangeRate":-0.212662},{"month":7,"riseRate":0.4,"avgChangeRate":0.059988},{"month":8,"riseRate":0.4,"avgChangeRate":0.05496},{"month":9,"riseRate":0.4,"avgChangeRate":-0.011761},{"month":10,"riseRate":0.4,"avgChangeRate":-0.000213},{"month":11,"riseRate":0.333333,"avgChangeRate":0.179457},{"month":12,"riseRate":0.5,"avgChangeRate":0.080552}],"exchange":"SEHK","name":"天星医疗","nameEN":"STAR SPORTS MED"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"天星医疗(01609)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供天星医疗(01609)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"天星医疗,01609,天星医疗股票,天星医疗股票老虎,天星医疗股票老虎国际,天星医疗行情,天星医疗股票行情,天星医疗股价,天星医疗股市,天星医疗股票价格,天星医疗股票交易,天星医疗股票购买,天星医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"天星医疗(01609)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供天星医疗(01609)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}